Chronic Intake of Energy Drinks and Their Sugar Free Substitution Similarly Promotes Metabolic Syndrome

Nutrients. 2021 Apr 6;13(4):1202. doi: 10.3390/nu13041202.

Abstract

Energy drinks containing significant quantities of caffeine, taurine and sugar are increasingly consumed, particularly by adolescents and young adults. The putative effects of chronic ingestion of either standard energy drink, MotherTM (ED), or its sugar-free formulation (sfED) on metabolic syndrome were determined in wild-type C57BL/6J mice, in comparison to a soft drink, Coca-Cola (SD), a Western-styled diet enriched in saturated fatty acids (SFA), and a combination of SFA + ED. Following 13 weeks of intervention, mice treated with ED were hyperglycaemic and hypertriglyceridaemic, indicating higher triglyceride glucose index, which was similar to the mice maintained on SD. Surprisingly, the mice maintained on sfED also showed signs of insulin resistance with hyperglycaemia, hypertriglyceridaemia, and greater triglyceride glucose index, comparable to the ED group mice. In addition, the ED mice had greater adiposity primarily due to the increase in white adipose tissue, although the body weight was comparable to the control mice receiving only water. The mice maintained on SFA diet exhibited significantly greater weight gain, body fat, cholesterol and insulin, whilst blood glucose and triglyceride concentrations remained comparable to the control mice. Collectively, these data suggest that the consumption of both standard and sugar-free forms of energy drinks induces metabolic syndrome, particularly insulin resistance.

Keywords: artificial sweetener; blood glucose; body fat; brown adipose tissue; cholesterol; energy drinks; insulin; metabolic syndrome; triglycerides.

MeSH terms

  • Adipose Tissue, White / physiopathology
  • Adiposity / physiology
  • Animals
  • Blood Glucose / analysis
  • Body Weight
  • Carbonated Beverages / adverse effects*
  • Diet, Western / adverse effects*
  • Disease Models, Animal
  • Energy Drinks / adverse effects*
  • Fatty Acids / administration & dosage
  • Fatty Acids / adverse effects
  • Humans
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / etiology*
  • Metabolic Syndrome / physiopathology
  • Mice
  • Mice, Inbred C57BL
  • Sweetening Agents / adverse effects
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Fatty Acids
  • Sweetening Agents
  • Triglycerides